Resistance Mechanisms to Taxanes and PARP Inhibitors in Advanced Prostate Cancer
{{output}}
The clinical landscape concerning advanced prostate cancer is rapidly changing and reaching beyond androgen deprivation therapy and androgen receptor targeted therapies. Taxane chemotherapy is a critical tool in the management of advanced prostate cancer. Addi... ...